New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
Despite economic caution, pharma and biotech leaders invest boldly to reshape pipelines and accelerate innovation.
Already a subscriber? Log in